The chemical class of ZBTB6 activators encompasses a variety of compounds found in natural sources such as plants. These activators exert their effects by targeting specific signaling pathways implicated in the regulation of ZBTB6 expression and activity.
Many of these activators, such as curcumin, parthenolide, and resveratrol, function by inhibiting the NF-κB signaling pathway. They prevent the phosphorylation and subsequent degradation of IκBα, thereby blocking the nuclear translocation of NF-κB and promoting the transcription of ZBTB6. Other activators, like withaferin A and gambogic acid, target the JAK/STAT signaling pathway. They suppress the phosphorylation of STAT3, leading to the inhibition of STAT3-mediated transcriptional activity and subsequent upregulation of ZBTB6 expression. Additionally, compounds such as emodin and baicalein activate ZBTB6 by modulating the Wnt/β-catenin signaling pathway. They inhibit the nuclear translocation of β-catenin, resulting in the downregulation of TCF/LEF-mediated transcription and enhancement of ZBTB6 expression. Overall, these ZBTB6 activators represent a diverse group of compounds that hold potential for modulating ZBTB6 expression and function through targeted manipulation of specific signaling pathways.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Guggulsterone | 95975-55-6 | sc-203990 sc-203990A | 10 mg 50 mg | $145.00 $615.00 | 1 | |
Guggulsterone, a plant sterol derived from Commiphora mukul, activates ZBTB6 by inhibiting the NF-κB signaling pathway. It prevents the phosphorylation and degradation of IκBα, thereby inhibiting the nuclear translocation of NF-κB and promoting the transcription of ZBTB6. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $117.00 $344.00 | 3 | |
Betulinic acid, a pentacyclic triterpenoid found in many plants, activates ZBTB6 by modulating the NF-κB signaling pathway. It inhibits the phosphorylation and degradation of IκBα, leading to the inhibition of NF-κB activation and subsequent upregulation of ZBTB6 expression. | ||||||